| __timestamp | ADMA Biologics, Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 5915545 | 15879000000 |
| Thursday, January 1, 2015 | 7177633 | 16560000000 |
| Friday, January 1, 2016 | 10661037 | 19427000000 |
| Sunday, January 1, 2017 | 22760560 | 20776000000 |
| Monday, January 1, 2018 | 16985290 | 22561000000 |
| Tuesday, January 1, 2019 | 29349083 | 26145000000 |
| Wednesday, January 1, 2020 | 42219783 | 42518000000 |
| Friday, January 1, 2021 | 80942625 | 46385000000 |
| Saturday, January 1, 2022 | 154079692 | 46159000000 |
| Sunday, January 1, 2023 | 258214999 | 45006000000 |
| Monday, January 1, 2024 | 48300000000 |
Cracking the code
In the ever-evolving landscape of biopharmaceuticals, Bristol-Myers Squibb Company and ADMA Biologics, Inc. present a fascinating study in contrasts. Over the past decade, Bristol-Myers Squibb has consistently demonstrated its market dominance, with revenues peaking at approximately $46 billion in 2021. This represents a staggering growth of nearly 190% since 2014. Meanwhile, ADMA Biologics, a smaller yet ambitious player, has shown remarkable growth, with revenues surging by over 4,200% from 2014 to 2023, reaching around $258 million.
This revenue trajectory highlights the dynamic nature of the biopharma sector, where established giants and emerging innovators coexist. As we look to the future, the question remains: will ADMA Biologics continue its upward trajectory, or will Bristol-Myers Squibb maintain its stronghold? The coming years promise to be an exciting chapter in this ongoing saga.
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Revenue Insights: Merck & Co., Inc. and Bristol-Myers Squibb Company Performance Compared
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Exelixis, Inc.
Bristol-Myers Squibb Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Alnylam Pharmaceuticals, Inc. or ADMA Biologics, Inc.: Who Leads in Yearly Revenue?
TG Therapeutics, Inc. vs ADMA Biologics, Inc.: Annual Revenue Growth Compared
ADMA Biologics, Inc. vs Taro Pharmaceutical Industries Ltd.: Examining Key Revenue Metrics
ADMA Biologics, Inc. vs Travere Therapeutics, Inc.: Annual Revenue Growth Compared